[go: up one dir, main page]

GT200100198A - DERIVATIVES OF PROPIONIC ACID. - Google Patents

DERIVATIVES OF PROPIONIC ACID.

Info

Publication number
GT200100198A
GT200100198A GT200100198A GT200100198A GT200100198A GT 200100198 A GT200100198 A GT 200100198A GT 200100198 A GT200100198 A GT 200100198A GT 200100198 A GT200100198 A GT 200100198A GT 200100198 A GT200100198 A GT 200100198A
Authority
GT
Guatemala
Prior art keywords
compounds
derivatives
propionic acid
formula
mediacament
Prior art date
Application number
GT200100198A
Other languages
Spanish (es)
Inventor
Kaus Urbhans
Michael Woltering
Susanne Nikolic
Josef Pernerstorfer
Berthold Hinzen
Elke Dittrich-Wengenroth
Hilmar Bischoff
Claudia Hirth-Dietrich
Klemens Lustig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200100198A publication Critical patent/GT200100198A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS COMPUESTOS POTENTES ACTIVADORES DE PPARALFA PARA EL TRATAMIENTO DE ENFERMEDADES CORONARIAS, LOS MEDIACAMENTO QUE EMPLEA ESTE TIPO DE COMPUESTOS ESTAN CONSTITUIDO POR UN COMPUESTO DE LA FORMULA (I), EXCIPIENTES, COADYUVANTES, DISOLVENTES, VEHICULOS EMULSIONANTES Y/O DISPERSANTES INERTES NO TOXICOS FARMACEUTICAMENTE ACEPTABLES. ESTOS COMPUESTOS ESTA REPRESENTADOS POR LA FORMULA QUIMICA (I), EN DONDE R1, R2, R3, R4, R5, R6, R6, R7, R8, R9, R10, R11, R12, R13, A Y X SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.THE PRESENT INVENTION REFERS TO NEW POWERFUL ACTIVATING COMPOUNDS OF PPARALFA FOR THE TREATMENT OF CORONARY DISEASES, THE MEDIACAMENT USED BY THIS TYPE OF COMPOUNDS ARE CONSTITUTED BY A COMPOUND OF FORMULA (I), EXCIPIENTS, OBLIGATING SPELLS PHARMACEUTICALLY ACCEPTABLE NON-TOXIC DISPERSANTS. THESE COMPOUNDS ARE REPRESENTED BY THE CHEMICAL FORMULA (I), WHERE R1, R2, R3, R4, R5, R6, R6, R7, R8, R9, R10, R11, R12, R13, AYX ARE FUNCTIONAL GROUPS DESCRIBED ON THE RECORD .

GT200100198A 2000-10-05 2001-10-01 DERIVATIVES OF PROPIONIC ACID. GT200100198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10049208 2000-10-05

Publications (1)

Publication Number Publication Date
GT200100198A true GT200100198A (en) 2002-06-25

Family

ID=7658699

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200100198A GT200100198A (en) 2000-10-05 2001-10-01 DERIVATIVES OF PROPIONIC ACID.

Country Status (9)

Country Link
KR (1) KR20030059175A (en)
AR (1) AR035203A1 (en)
DE (1) DE10124905A1 (en)
DO (1) DOP2001000260A (en)
EC (1) ECSP034536A (en)
GT (1) GT200100198A (en)
PE (1) PE20020475A1 (en)
SV (1) SV2002000677A (en)
ZA (1) ZA200302610B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111020A1 (en) * 2003-06-06 2004-12-23 F. Hoffmann-La Roche Ag Aniline derivatives
KR100699928B1 (en) 2004-10-05 2007-03-26 재단법인서울대학교산학협력재단 Method for preparing intermediates for the preparation of peroxysomal proliferator activated receptor alpha ligands

Also Published As

Publication number Publication date
SV2002000677A (en) 2002-12-02
ZA200302610B (en) 2004-04-05
AR035203A1 (en) 2004-05-05
DE10124905A1 (en) 2002-04-11
ECSP034536A (en) 2003-05-26
PE20020475A1 (en) 2002-06-08
DOP2001000260A (en) 2002-12-15
KR20030059175A (en) 2003-07-07

Similar Documents

Publication Publication Date Title
GT200100137A (en) PRO-DRUGS OF 4-PHENYL-PYRIDINE DERIVATIVES.
AR043436A1 (en) SUBSTITUTED TETRAHYDROISOQUINOLINS FOR USE AS 5-HT6 MODULATORS
UY26872A1 (en) DERIVATIVES OF THE 4- PIRIDINE PHENYL
DE60315615D1 (en) THYOPHICAL BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CO4810375A1 (en) DERIVATIVES OF 9-AMINO-3-KETO Erythromycin
AR029216A1 (en) NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE
CY1105301T1 (en) ARYL-FUSED AZAPOLYCYCLIC COMPOUNDS
CY1105035T1 (en) ARYLY OR HETERARYLY FUSED IMIDAZOLE DERIVATIVES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
AR042002A1 (en) SUBSTITUTED BENZOXAZINONAS, OBTAINING PROCESS AND USES FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
PA8576101A1 (en) DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE
DOP2002000399A (en) NEW DERIVATIVES OF SULFONIC ACID
UY27803A1 (en) DERIVATIVES OF BENZOXAZINE AND USES OF THE SAME.
CY1109085T1 (en) NEW SALTS
PA8575001A1 (en) FLUOROBENZAMIDS AS MAOB INHIBITORS
GT200200259A (en) FUNGICIDES
PE20030705A1 (en) 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
GT200100251A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOTRIAZINONES SUBSTITUTED WITH SULFONAMIDE
PA8589801A1 (en) AMINOALCOXYINDOLS
SE8102220L (en) USE OF SUBSTITUTED DERIVATIVES OF 4-PHENYL-4-OXO-2-BUTENIC ACID AS A MEDICINE
GT200100198A (en) DERIVATIVES OF PROPIONIC ACID.
ATE337827T1 (en) N-ARYL-4,5-DIAMINOPYRAZOLES AND DYES CONTAINING THESE COMPOUNDS
ES8304976A1 (en) "PROCEDURE FOR THE PREPARATION OF SUBSTITUTED TRYPTAMINIC DERIVATIVES OF THENYLOXYPROPANOLAMINS, RACEMICS AND OPTICALLY ACTIVE".
CR6503A (en) DERIVATIVES OF- 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETICLCROMANO
PE20011062A1 (en) CALCILITIC COMPOUNDS
AR044320A1 (en) 3-DECLADINOSIL DERIVATIVES OF THE CLASS OF 9A - N-CARBAMOIL - AND 9A-NTIOCARBAMOIL- 9 DIHIDRO-9A AZA- 9A - HOMOERITHROMYCIN A